Galileo Research Facts No. 73: Does Galileo Therapy increase Creatine Kinase levels in Duchenne patients?

Galileo Research Facts No. 73: Does Galileo Therapy increase Creatine Kinase levels in Duchenne patients?

This pilot study tested the effects of Galileo Therapy on Creatine Kinase (CK) levels in children with Duchenne Muscle Dystrophy (DMD, Age 4-14). (Flexed legs, 13-20Hz, pos. 2, 2*2 min., 3/week, 4 weeks). Galileo Training did not show any significant increases in CK levels during the 4 weeks of Galileo Therapy. This study shows a relevant safety aspect of Galileo Therapy for DMD patients...
Continue reading
Galileo Research Facts No. 58: Can Galileo Therapy increase muscle power and flexibility in spinal muscle atrophy (SMA)?

Galileo Research Facts No. 58: Can Galileo Therapy increase muscle power and flexibility in spinal muscle atrophy (SMA)?

This study explored the effects of Galileo Therapy on muscle power and flexibility in kids with spinal muscle atrophy (SMA) (3x3min., 10/week, 18-24Hz, pos. 2., knees bent slightly, Stretching, 8 weeks, 4 weeks follow-up). Even though this study was designed as a safety study only (low intensity Galileo Therapy) it showed significant increases in muscle power and flexibility of up to 36% during just 8 weeks of Galileo Therapy...
Continue reading
Galileo Research Facts No. 57: Can Galileo Therapy in Duchenne muscle dystrophy increase muscle power and force?

Galileo Research Facts No. 57: Can Galileo Therapy in Duchenne muscle dystrophy increase muscle power and force?

This study explored the effects of Galileo Therapy on muscle power and muscle force in kids with Duchenne muscle dystrophy (3x3min., 10/week, 18-24Hz, pos. 2., knees bent slightly, Stretching, 8 weeks, 4 weeks follow-up). Even though this study was designed as a safety study only (low intensity Galileo Therapy) it showed significant increases in muscle power and muscle force of up to 12% during the 8 weeks of training...
Continue reading